![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
암호화폐 뉴스 기사
Pharmaceutical distributor Wellgistics Health (WGRX) is backing XRP as a treasury and payments asset
2025/05/09 15:28
Florida-based pharmaceutical distributor Wellgistics Health (WGRX) has announced that it will be integrating XRP into its treasury and payments operations as part of a $50 million financing deal.
The company has secured an equity line of credit with LDA Capital, a New York-based firm specializing in direct lending and investment banking services.
The move will see Wellgistics use blockchain technology to streamline transactions across its pharmacy network, handling vendor payouts and issuing credit lines with XRP.
Wellgistics stocks rose more than 14% on Thursday.
The company plans to use XRP to settle transactions quickly, in 3-5 seconds compared to 1-3 days for ACH or wire transfers, enabling near real-time settlement among pharmacies, suppliers, and manufacturers.
All transactions will be logged on the XRP Ledger for real-time compliance, rebate tracking, and auditability. The token will also help process global vendor payouts at very low foreign exchange rates.
“We believe that there are certain advantages to integrating XRP and its related infrastructure into its healthcare ecosystem,” the firm said in the statement.
“XRP, a rapidly growing token in the cryptocurrency market, is known for its speed of transaction settlement, typically completed in 3-5 seconds, compared to 1-3 days for ACH or wire transfers, allowing for near real-time settlement among pharmacies, suppliers, and manufacturers.”
The company is focused on eliminating banking delays and reducing settlement costs to fractions of a cent, two key difficulties in pharmaceutical supply chains.
Moreover, the company will be able to track government-issued drug rebates in real-time, ensuring timely processing and reducing administrative burdens.
The company’s statement also highlights the importance of cross-border payments in the pharmaceutical industry, which are usually subject to high foreign exchange fees.
However, XRP’s ارز دیجیتال will facilitate global vendor payouts at very low foreign exchange rates, a significant advantage for an industry with a global footprint.
While the company plans to integrate XRP and its related infrastructure, the company did not disclose a timeline for when these services would actually begin.
부인 성명:info@kdj.com
제공된 정보는 거래 조언이 아닙니다. kdj.com은 이 기사에 제공된 정보를 기반으로 이루어진 투자에 대해 어떠한 책임도 지지 않습니다. 암호화폐는 변동성이 매우 높으므로 철저한 조사 후 신중하게 투자하는 것이 좋습니다!
본 웹사이트에 사용된 내용이 귀하의 저작권을 침해한다고 판단되는 경우, 즉시 당사(info@kdj.com)로 연락주시면 즉시 삭제하도록 하겠습니다.